ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V306. A total of 17 filers reported holding ONCONOVA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $26,000 | -96.1% | 63,218 | -92.1% | 0.00% | -90.0% |
| Q1 2018 | $668,000 | -20.7% | 799,160 | +42.4% | 0.04% | -48.1% |
| Q4 2017 | $842,000 | -41.4% | 561,163 | -33.3% | 0.08% | -18.1% |
| Q3 2017 | $1,438,000 | -15.1% | 840,960 | +7.3% | 0.09% | -15.3% |
| Q2 2017 | $1,693,000 | +45.3% | 784,000 | +104.0% | 0.11% | +76.2% |
| Q1 2017 | $1,165,000 | +13.3% | 384,360 | -15.1% | 0.06% | +5.0% |
| Q4 2016 | $1,028,000 | -1.1% | 452,804 | +15.5% | 0.06% | +53.8% |
| Q3 2016 | $1,039,000 | – | 392,023 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYNDALL CAPITAL PARTNERS L P | 520,832 | $1,453,000 | 78.80% |
| Boxer Capital, LLC | 316,386 | $838,000 | 0.38% |
| SABBY MANAGEMENT, LLC | 392,023 | $1,039,000 | 0.04% |
| Alambic Investment Management, L.P. | 13,500 | $36,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 24,087 | $64,000 | 0.00% |
| EAGLE GLOBAL ADVISORS LLC | 16,680 | $44,000 | 0.00% |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2 | $0 | 0.00% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 77 | $0 | 0.00% |
| CITIGROUP INC | 1,187 | $3,000 | 0.00% |